Pfizer nears deal to acquire Medivation for close to $14 billion
(Reuters) - Pfizer Inc is in advanced talks to acquire U.S. cancer drug company Medivation Inc for close to $14 billion, as it seeks to boost its oncology portfolio, people familiar with the matter said on Sunday.
No comments:
Post a Comment